JR Kent, AJ Bischoff, LJ Arduino… - The Journal of …, 1973 - auajournals.org
RESULTS Pre-treatment testosterone levels. Among the 68 patients with stage III disease the plasma testosterone was 0.56 plus or minus 0.257 µg. per 100 ml.(mean plus or minus …
D Hickey, B Todd, MS Soloway - The Journal of urology, 1986 - Elsevier
Abstract From June 1982 to February 1985, 53 patients with stage D2 carcinoma of the prostate confirmed by tissue biopsy, elevated prostatic acid phosphatase and a positive …
P Iversen, F Rasmussen… - Scandinavian journal of …, 1994 - europepmc.org
In 245 patients with previously untreated advanced carcinoma of the prostate, serum concentrations of testosterone have been measured before androgen deprivation therapy …
RJ Shearer, WF Hendry, IF Sommerville… - British Journal of …, 1973 - Wiley Online Library
Plasma testosterone has been estimated by radioimmunoassay in 109 patients with prostatic carcinoma and 18 men of similar age with benign prostatic hyperplasia. Stilboestrol …
K Isurugi - The Journal of Urology, 1967 - auajournals.org
Since Huggins and Hodges demonstrated androgen-dependence of prostatic cancer, 1 many investigators have shown that anti-androgenic treatment, including estrogen …
J Geller, JD Albert, DA Nachtsheim, D Loza - The Journal of urology, 1984 - Elsevier
Dihydrotestosterone concentrations have been measured in prostatic tissue from patients with recurrent advanced prostatic cancer after 1.0 to 5.0 mg. diethylstilbestrol per day or …
Twenty‐six men in whom the diagnosis of prostatic carcinoma had been established recently and ten men with prostatic carcinoma in relapse after orchiectomy were …
HF Røhl, HP Beuke - Scandinavian journal of urology and …, 1992 - Taylor & Francis
Because it is well known that prostatic cancer is dependent on testosterone, and that dihydrotestosterone is the active mediator of the androgen action in the prostatic cell, we …
With accurate, inexpensive plasma testosterone assays now available it is possible to monitor the efficacy of hormonal manipulation in the patient with adenocarcinoma of the …